STipe Therapeutics Employee Directory
Biotechnology ResearchSouth Denmark, Denmark11-50 Employees
STipe Therapeutics is a privately held biotechnology company focused on immune-oncology, pursuing therapies that leverage a novel aspect of the STING pathway to target cancer. The company is based in South Denmark, Denmark, and has a workforce of 11 to 50 employees. It originated as a spin-out of Aarhus University in 2018 and completed a EUR 20 million Series A financing in September 2019. In 2022, STipe Therapeutics appointed Dr. Richard Sainson as Chief Scientific Officer, effective June 6. The company has issued notices about job recruitment scams and states it does not conduct formal job interviews via social media platforms.